General form of registration statement for all companies including face-amount certificate companies

Income Taxes (Details Narrative) (10-K)

v3.19.3.a.u2
Income Taxes (Details Narrative) (10-K) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Deferred tax liability $ 3,037,147   $ 3,037,147   $ 3,037,147  
Deferred tax liability, financial reporting basis 11,038,929   11,038,929   11,038,929  
Deferred tax liability, tax basis 1,782   1,782   1,782  
Income tax benefit $ 141,251 $ 212,015 $ 442,152 $ 771,332 $ 902,801
Income tax description         Revalue our U.S. deferred tax assets and liabilities due to the federal income tax rate reduction from 35 percent to 21 percent.  
Federal income tax rate         21.00% 34.00%
Operating loss description         However, these tax-loss carry forwards can only offset 80 percent of future taxable income in any one year, with respect to any excess continuing to be carried forward indefinitely.  
Provisional amount fully offset by valuation of allowance         $ 72,300  
Research and development tax credits        
Deferred tax loss carryforward         733,560 71,283
Change in valuation of allowance         329,755 166,787
Deferred tax start-up expenditures for tax purposes         1,703,904 347,530
Start-up expenditures and amortization         468,872 95,504
Deferred tax loss carryforward         $ 2,665,796 258,583
Maryland [Member]            
Research and development tax credits carryforward period         7 years  
Tax Cuts and Jobs Act [Member]            
Income tax description         On December 22, 2017, the Tax Cuts and Jobs Act of 2017 ("TCJA") was signed into law. Among its provisions, the TCJA reduces the statutory U.S. Corporate income tax rate from 34% to 21% effective January 1, 2018.  
Federal [Member]            
Net operating loss carryforward         $ 2,700,000 $ 259,000
Net operating loss carryforward description         expire from 2019 through 2037 expire from 2019 through 2037
Research and development tax credits carryforward period         20 years  
Deferred tax loss carryforward         $ 4,369,700  
State [Member]            
Net operating loss carryforward         $ 2,700,000 $ 259,000
Net operating loss carryforward description         expire from 2028 to 2037 expire from 2028 to 2037
Deferred tax loss carryforward         $ 606,113  
Promet [Member]            
Common stock issued and outstanding percentage         90.00%